Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use

Journal of the American Board of Family Medicine: JABFM

article

Nancy Crego¹  Christian Douglas¹  Emily Bonnabeau¹  Marian Earls²  Kern Eason²  Elizabeth Merwin³  Gary Rains⁴  Paula Tanabe¹  Nirmish Shah⁵ 

[1] From Duke University School of Nursing;Community Care of North Carolina;University of Texas College of Nursing;Duke University School of Medicine;Duke University Medical Center

关键词: Child Health;    Emergency Departments;    Hematology;    Hospitalization;    Hydroxyurea;    Medicaid;    Minority Health;    North Carolina;    Primary Health Care;    Sickle-Cell Anemia;    Vulnerable Populations;   

DOI  :  10.3122/jabfm.2020.01.190143

学科分类：过敏症与临床免疫学

来源: The American Board of Family Medicine

【 摘 要 】

Background: Sickle-cell disease (SCD) causes significant morbidity, premature mortality, and high disease burden, resulting in frequent health care use. Comanagement may improve utilization and patient adherence with treatments such as Hydroxyurea. The purpose of this study was to describe acute-care utilization in Medicaid-enrolled patients with SCD, patient factors associated with comanagement, and adherence to Hydroxyurea.

【 授权许可】

CC BY